EQS-AFR: Evotec SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements ...

BeiGene's Tevimbra approved for ESCC with chemo, Tenaya plans $52.5M offering, Evotec gets $20M from Bristol Myers Squibb, and Osivax raises €10M for flu vaccine research ...

This page uses Cookies. For proper functioning of the page Cookies are needed. You agree to using Cookies by clicking "OK". More infos can be found in our Privacy declaration . If you disagree this ...

Triggers a $20 million research payment to Evotec, enabling further development of a preclinical program in neurodegeneration ...

The collaboration has already yielded strong results, including the in-licensing of EVT8683 (now BMS-986419) by Bristol Myers Squibb in September 2021. In March 2023, the companies reaffirmed their ...

Ongoing strategic partnership advances joint pipeline in neurodegeneration researchEvotec receives a $20 million payment to further progress research HAMBURG, DE / ACCESS Newswire / March 4, 2025 / Ev ...

Ongoing strategic partnership advances joint pipeline in neurodegeneration research Evotec receives a $20 million payment to ...